Soluble form of canine transferrin receptor inhibits canine parvovirus infection in vitro and in vivo

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Wen, Jiexia ^a,b   Pan, Sumin ^a,b,c   Liang, Shuang ^d   Zhong, Zhenyu ^e   He, Ying ^b   Lin, Hongyu ^f   Li, Wenyan ^a,b   Wang, Liyue ^a,b   Li, Xiujin ^f   Zhong, Fei ^a,b  

^a AGRICULTURAL UNIVERSITY OF HEBEI   (China)

^b HEBEI NORMAL UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c North China Research Center of Animal Epidemic Pathogen Biology China Agriculture Ministry   (China)

^d LOYOLA UNIVERSITY HEALTH SYSTEM   (United States)

^e LOYOLA UNIVERSITY CHICAGO   (United States)

^f YANSHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN VP2; RECOMBINANT PROTEIN; RECOMBINANT SOLUBLE TRANSFERRIN RECEPTOR; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG; CAPSID PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIVIRAL ACTIVITY; ARTICLE; CELL STRAIN HEK293; CODON; CONTROLLED STUDY; DOG; DRUG BINDING; FELINE PANLEUKOPENIA; FELINE PANLEUKOPENIA VIRUS; GENE EXPRESSION; GENE STRUCTURE; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; VIRUS STRAIN; ANIMAL; ANIMAL DISEASE; CELL CULTURE; GENETICS; HEK293 CELL LINE; METABOLISM; PARVOVIRUS INFECTION; PATHOGENICITY; PROTEIN BINDING; VIROLOGY;

ANIMALS; CAPSID PROTEINS; CELLS, CULTURED; DOGS; HEK293 CELLS; HUMANS; PARVOVIRIDAE INFECTIONS; PARVOVIRUS, CANINE; PROTEIN BINDING; RECEPTORS, TRANSFERRIN; RECOMBINANT PROTEINS;

EID: 84884892633     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/172479     Document Type: Article

References (25)

1. Thomson G. W., Gagnon A. N., Canine gastroenteritis associated with a parvovirus-like agent. The Canadian Veterinary Journal 1978 19 12 346 364 2-s2.0-0018110014
2. Parrish C. R., O'Connell P. H., Evermann J. F., Carmichael L. E., Natural variation of canine parvovirus. Science 1985 230 4729 1046 1048 2-s2.0-0022380683 (Pubitemid 16192693)
3. Decaro N., Buonavoglia C., Canine parvovirus-a review of epidemiological and diagnostic aspects, with emphasis on type 2c. Veterinary Microbiology 2012 155 1 1 12 2-s2.0-84855865278 10.1016/j.vetmic.2011.09.007
4. Hueffer K., Parker J. S. L., Weichert W. S., Geisel R. E., Sgro J.-Y., Parrish C. R., The natural host range shift and subsequent evolution of canine parvovirus resulted from virus-specific binding to the canine transferrin receptor. Journal of Virology 2003 77 3 1718 1726 2-s2.0-0037302252 10.1128/JVI.77.3.1718-1726.2003 (Pubitemid 36109983)
5. Hueffer K., Govindasamy L., Agbandje-McKenna M., Parrish C. R., Combinations of two capsid regions controlling canine host range determine canine transferrin receptor binding by canine and feline parvoviruses. Journal of Virology 2003 77 18 10099 10105 2-s2.0-0141570405 10.1128/JVI.77.18.10099- 10105.2003 (Pubitemid 37122091)
6. Parker J. S. L., Murphy W. J., Wang D., O'Brien S. J., Parrish C. R., Canine and feline parvoviruses can use human or feline transferrin receptors to bind, enter, and infect cells. Journal of Virology 2001 75 8 3896 3902 2-s2.0-0035085754 10.1128/JVI.75.8.3896-3902.2001 (Pubitemid 32246398)
7. Hueffer K., Palermo L. M., Parrish C. R., Parvovirus infection of cells by using variants of the feline transferrin receptor altering clathrin-mediated endocytosis, membrane domain localization, and capsid-binding domains. Journal of Virology 2004 78 11 5601 5611 2-s2.0-2442689164 10.1128/JVI.78.11.5601-5611. 2004 (Pubitemid 38661647)
8. Lawrence C. M., Ray S., Babyonyshev M., Galluser R., Borhani D. W., Harrison S. C., Crystal structure of the ectodomain of human transferrin receptor. Science 1999 286 5440 779 782 2-s2.0-0033595794 10.1126/science.286. 5440.779 (Pubitemid 29505890)
9. Luck A. N., Mason A. B., Transferrin-mediated cellular iron delivery. Current Topics in Membranes 2012 69 3 35 10.1016/B978-0-12-394390-3.00001-X
10. Ibricevic A., Pekosz A., Walter M. J., Newby C., Battaile J. T., Brown E. G., Holtzman M. J., Brody S. L., Influenza virus receptor specificity and cell tropism in mouse and human airway epithelial cells. Journal of Virology 2006 80 15 7469 7480 2-s2.0-33746215109 10.1128/JVI.02677-05 (Pubitemid 44092569)
11. Vermeire K., Schols D., Bell T. W., Inhibitors of HIV infection via the cellular CD4 receptor. Current Medicinal Chemistry 2006 13 7 731 743 2-s2.0-33645982253 10.2174/092986706776055599
12. Vermeire K., Schols D., Anti-HIV agents targeting the interaction of gp120 with the cellular CD4 receptor. Expert Opinion on Investigational Drugs 2005 14 10 1199 1212 2-s2.0-27144534021 10.1517/13543784.14.10.1199 (Pubitemid 41488869)
13. Marlin S. D., Staunton D. E., Springer T. A., Stratowa C., Sommergruber W., Merluzzi V. J., A soluble form of intercellular adhesion molecule-1 inhibits rhinovirus infection. Nature 1990 344 6261 70 72 2-s2.0-0025058803
14. Pöhlmann S., Doms R. W., Evaluation of current approaches to inhibit HIV entry. Current Drug Targets-Infectious Disorders 2002 2 1 9 16 2-s2.0-0035984979 (Pubitemid 34649851)
15. Leung K. M., Feng D. X., Lou J., Zhou Y., Fung K. P., Waye M. M. Y., Tsui S. K. W., Chan P. K. S., Marks J. D., Pang S. F., Kan Y. W., Development of human single-chain antibodies against SARS-associated coronavirus. Intervirology 2008 51 3 173 181 2-s2.0-49849083608 10.1159/000151530
16. Che P., Wang L., Li Q., The development, optimization and validation of an assay for high throughput antiviral drug screening against dengue virus. International Journal of Clinical and Experimental Medicine 2009 2 4 363 373 2-s2.0-74549219339
17. Li Q., Maddox C., Rasmussen L., Hobrath J. V., White L. E., Assay development and high-throughput antiviral drug screening against Bluetongue virus. Antiviral Research 2009 83 3 267 273 2-s2.0-68249102137 10.1016/j.antiviral.2009.06.004
18. Deen K. C., McDougal J. S., Inacker R., Folena-Wasserman G., Arthos J., Rosenberg J., Maddon P. J., Axel R., Sweet R. W., A soluble form of CD4 (T4) protein inhibits AIDS virus infection. Nature 1988 331 6151 82 84 2-s2.0-0023845937 (Pubitemid 18053422)
19. Wang W., Li X., Wang X., Han D., Pan S., Zhong F., Establishment of CHO-K1 cell lines stably expressing canine parvovirus VP2 structure protein. Chinese Journal of Veterinary Science 2010 30 5 588 592
20. Wang W., Li X., Zhong F., Wang X., Han D., Jin H., Pan S., Li W., Secreting expression and characterization of canine parvovirus VP2 protein in eukaryotic cells. Wei Sheng Wu Xue Bao 2009 49 5 648 652 2-s2.0-70349248559
21. Jin H., Zhong F., Wu L., Xie M., Wang W., Han D., Construction of eukaryotic expression vector carrying canine β -defensin-1 gene and its expression in HEK293T cells. Current Zoology 2008 54 5 897 902
22. Pan S., Li X., Zhong F., Wang X., Han D., Wang W., Study on codon optimization and expression of canine sTfR gene in eukaryotic cells and interaction with canine parvovirus VP2 protein. Chinese Journal of Veterinary Science 2009 29 12 1539 1543
23. Derman A. I., Prinz W. A., Belin D., Beckwith J., Mutations that allow disulfide bond formation in the cytoplasm of Escherichia coli. Science 1993 262 5140 1744 1747 2-s2.0-0027739665 (Pubitemid 24030100)
24. Zakhartchouk A. N., Viswanathan S., Moshynskyy I., Petric M., Babiuk L. A., Optimization of a DNA vaccine against SARS. DNA and Cell Biology 2007 26 10 721 726 2-s2.0-38449107834 10.1089/dna.2007.0616
25. Palermo L. M., Hueffer K., Parrish C. R., Residues in the apical domain of the feline and canine transferrin receptors control host-specific binding and cell infection of canine and feline parvoviruses. Journal of Virology 2003 77 16 8915 8923 2-s2.0-0041707788 10.1128/JVI.77.16.8915-8923.2003 (Pubitemid 36936101)